Sale!

MSH6 Gene Endometrial Cancer Familial MSH6 Related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MSH6 gene is a critical component in the DNA mismatch repair system, which helps maintain the integrity of genetic information. Mutations in the MSH6 gene are associated with an increased risk of developing endometrial cancer, among other cancers, as part of Lynch syndrome, a hereditary condition. Recognizing the significance of early detection in managing and reducing the risk of cancer, DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the MSH6 gene that are linked to familial endometrial cancer.

This genetic test is a powerful tool for individuals with a family history of endometrial cancer or Lynch syndrome, providing them with crucial information regarding their genetic predisposition to the disease. By understanding their risk, individuals can make informed decisions about their health, including taking preventive measures or undergoing more frequent screenings to catch and treat cancer at an early stage, if it develops.

The test is conducted with a high degree of accuracy and confidentiality at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the MSH6 gene endometrial cancer familial-related genetic test is 4400 AED. This investment in one’s health provides invaluable insights, empowering individuals and their healthcare providers to tailor a personalized approach to cancer prevention and early detection, significantly impacting their overall well-being and life expectancy.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MSH6 Gene Endometrial Cancer Familial MSH6 Related Genetic Test

Test Name: MSH6 Gene Endometrial Cancer Familial MSH6 Related Genetic Test

Components: MSH6 gene

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for MSH6 Gene Endometrial Cancer, Familial, MSH6 Related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MSH6 Gene Endometrial Cancer, Familial, MSH6 Related NGS Genetic DNA Test gene MSH6.

Test Details: MSH6 gene is a gene that provides instructions for making a protein called MutS homolog 6 (MSH6). This protein is involved in the repair of mistakes that occur during DNA replication. Mutations in the MSH6 gene can lead to a condition called familial endometrial cancer, which is a hereditary form of endometrial cancer. Familial endometrial cancer, MSH6 related, is characterized by an increased risk of developing endometrial cancer at a younger age than usual. Individuals with this condition also have an increased risk of developing other types of cancer, including colorectal, ovarian, and stomach cancer.

To determine if a person has a mutation in the MSH6 gene, a genetic test called next-generation sequencing (NGS) can be performed. NGS is a technique that allows for the simultaneous sequencing of multiple genes, including the MSH6 gene, to identify any mutations or variations. The MSH6-related NGS genetic test involves obtaining a sample of DNA, usually through a blood sample or cheek swab, and analyzing it in a laboratory. The DNA is sequenced using NGS technology, and any variations or mutations in the MSH6 gene are identified and reported.

The results of the MSH6-related NGS genetic test can help determine if an individual has a mutation in the MSH6 gene and is at increased risk for developing familial endometrial cancer. This information can be used to guide medical management and screening recommendations for the individual and their family members.

It is important to note that genetic testing for familial endometrial cancer, MSH6 related, should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and guidance.

Test Name MSH6 Gene Endometrial cancer familial MSH6 related Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MSH6 Gene Endometrial cancer, familial, MSH6 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MSH6 Gene Endometrial cancer, familial, MSH6 related NGS Genetic DNA Test gene MSH6
Test Details

MSH6 gene is a gene that provides instructions for making a protein called MutS homolog 6 (MSH6). This protein is involved in the repair of mistakes that occur during DNA replication. Mutations in the MSH6 gene can lead to a condition called familial endometrial cancer, which is a hereditary form of endometrial cancer.

Familial endometrial cancer, MSH6 related, is characterized by an increased risk of developing endometrial cancer at a younger age than usual. Individuals with this condition also have an increased risk of developing other types of cancer, including colorectal, ovarian, and stomach cancer.

To determine if a person has a mutation in the MSH6 gene, a genetic test called next-generation sequencing (NGS) can be performed. NGS is a technique that allows for the simultaneous sequencing of multiple genes, including the MSH6 gene, to identify any mutations or variations.

The MSH6-related NGS genetic test involves obtaining a sample of DNA, usually through a blood sample or cheek swab, and analyzing it in a laboratory. The DNA is sequenced using NGS technology, and any variations or mutations in the MSH6 gene are identified and reported.

The results of the MSH6-related NGS genetic test can help determine if an individual has a mutation in the MSH6 gene and is at increased risk for developing familial endometrial cancer. This information can be used to guide medical management and screening recommendations for the individual and their family members.

It is important to note that genetic testing for familial endometrial cancer, MSH6 related, should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and guidance.